← Back to Search

Physical Therapy for Traumatic Brain Injury (B-HIST Trial)

Phase 2
Recruiting
Led By Candy Tefertiller, DPT, PhD
Research Sponsored by Craig Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how different types of therapeutic approaches can help improve mobility and balance after a TBI.

Who is the study for?
This trial is for adults who've had a traumatic brain injury (TBI) and are experiencing slower walking speeds. They should be within six months post-injury, weigh under 298 pounds, be shorter than 6'2", able to walk ten feet with minimal assistance, and have completed initial inpatient rehab for TBI. Those with uncontrolled health issues or participating in other trials can't join.
What is being tested?
The study tests three methods to improve mobility after TBI: standard gait and balance training; high intensity step training (HIST); and HIST combined with virtual reality. It aims to see if these treatments also enhance cognitive functions alongside physical abilities like balance.
What are the potential side effects?
While the trial primarily involves physical therapy interventions which typically have low risk, potential side effects may include muscle soreness, fatigue, joint pain or discomfort from the exercise equipment used during therapy sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Walking Speed
Secondary study objectives
Balance
Participant Enjoyment
Walking Endurance
Other study objectives
Cognition

Side effects data

From 2011 Phase 4 trial • 127 Patients • NCT01250184
10%
Hematomas
100%
80%
60%
40%
20%
0%
Study treatment Arm
Lidocaine Injection + Physical Therapy
Physical Therapy
Lidocaine Injection

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: High Intensity Step Training with Virtual Reality (HISTVR)Experimental Treatment1 Intervention
The third arm combines virtual reality with HIST, designed to increase cortical excitability while concurrently activating the neuromuscular system.
Group II: High Intensity Step Training (HIST)Experimental Treatment1 Intervention
High Intensity Step Training (HIST) focuses on the repetition of stepping at higher cardiovascular intensities and yielding a greater number of steps per training session.
Group III: Conventional Gait and Balance Training (CGBT)Active Control1 Intervention
The current approach for walking retraining, Conventional Gait and Balance Training (CGBT) focuses on walking training in a variety of conditions, obstacle management training, functional independence training, strength training, and standing dynamic balance training.

Find a Location

Who is running the clinical trial?

Craig HospitalLead Sponsor
42 Previous Clinical Trials
8,353 Total Patients Enrolled
Candy Tefertiller, DPT, PhDPrincipal InvestigatorCraig Hospital

Media Library

High Intensity Step Training Clinical Trial Eligibility Overview. Trial Name: NCT05702138 — Phase 2
Traumatic Brain Injury Research Study Groups: Conventional Gait and Balance Training (CGBT), High Intensity Step Training (HIST), High Intensity Step Training with Virtual Reality (HISTVR)
Traumatic Brain Injury Clinical Trial 2023: High Intensity Step Training Highlights & Side Effects. Trial Name: NCT05702138 — Phase 2
High Intensity Step Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05702138 — Phase 2
~58 spots leftby Dec 2026